Abstract
In this study, anti-inflammatory, wound healing and anti-ulcerogenic properties of chitosan were evaluated ‘in vivo’ using wistar rats and swiss adult mice and the anti-proliferative activity was tested ‘in vitro’. The tested chitosans displayed no anti-proliferative or anti-inflammatory properties. The cytotoxic activity of chitosan was found to be non-existent towards eight tumoral cell lines and no significant differences were found in the ear edema (anti-inflammatory model) induced by croton oil and chitosan groups. However, chitosan showed good anti-ulcerative and wound healing abilities. Low molecular weight (LMW) chitosan effectively reduced ulcerative wounds induced by ethanol, while high molecular weight (HMW) chitosan helped retain the stomachal folds rendering a gastro protective effect. These results suggest that chitosan can potentially be used in the treatment of peptic ulcers. HMW chitosan also potentiated the healing process both in normal and diabetic rats, probably without induction of fibroblast growth but via collagen synthesis.
Keywords: Chitosan, wound healing, anti-ulcerative, anti-proliferative, biological properties, in vivo testing.
Current Bioactive Compounds
Title:Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan
Volume: 12 Issue: 2
Author(s): Freni K. Tavaria, Michelle P. Jorge, Ana Lúcia T.G. Ruiz, Manuela E. Pintado and Joao E. Carvalho
Affiliation:
Keywords: Chitosan, wound healing, anti-ulcerative, anti-proliferative, biological properties, in vivo testing.
Abstract: In this study, anti-inflammatory, wound healing and anti-ulcerogenic properties of chitosan were evaluated ‘in vivo’ using wistar rats and swiss adult mice and the anti-proliferative activity was tested ‘in vitro’. The tested chitosans displayed no anti-proliferative or anti-inflammatory properties. The cytotoxic activity of chitosan was found to be non-existent towards eight tumoral cell lines and no significant differences were found in the ear edema (anti-inflammatory model) induced by croton oil and chitosan groups. However, chitosan showed good anti-ulcerative and wound healing abilities. Low molecular weight (LMW) chitosan effectively reduced ulcerative wounds induced by ethanol, while high molecular weight (HMW) chitosan helped retain the stomachal folds rendering a gastro protective effect. These results suggest that chitosan can potentially be used in the treatment of peptic ulcers. HMW chitosan also potentiated the healing process both in normal and diabetic rats, probably without induction of fibroblast growth but via collagen synthesis.
Export Options
About this article
Cite this article as:
K. Tavaria Freni, P. Jorge Michelle, Lúcia T.G. Ruiz Ana, E. Pintado Manuela and E. Carvalho Joao, Anti-Proliferative, Anti-Inflammatory, Anti-Ulcerogenic and Wound Healing Properties of Chitosan, Current Bioactive Compounds 2016; 12 (2) . https://dx.doi.org/10.2174/1573407212666160330204522
DOI https://dx.doi.org/10.2174/1573407212666160330204522 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Perinatal Gene Transfer to the Liver
Current Pharmaceutical Design Apoptotic Potency of Angiostatic Compounds in the Treatment of Cancer
Current Pharmaceutical Biotechnology Role of Prolyl Isomerase Pin1 in Pathogenesis of Diseases and Remedy for the Diseases from Natural Products
Current Drug Targets Antiviral Drug Discovery Targeting to Viral Proteases
Current Pharmaceutical Design Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Current Medicinal Chemistry Ex Vivo Gene Transfer for Improvement of Transplanted Pancreatic Islet Viability and Function
Current Pharmaceutical Design Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Targeting Cancer Stem Cells: Promises and Challenges
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective
Current Pharmaceutical Design Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Phytoestrogens and Mitochondrial Biogenesis in Breast Cancer. Influence of Estrogen Receptors Ratio
Current Pharmaceutical Design Recent Progress: Gynecologic Oncology Group Trials in Uterine Corpus Tumors
Reviews on Recent Clinical Trials New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Current Medicinal Chemistry Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism HPV-mediated Cervical Cancer: A Systematic Review on Immunological Basis, Molecular Biology, and Immune Evasion Mechanisms
Current Drug Targets Hierarchy of Knowledge Translation: From Health Problems to Ad-Hoc Drug Design
Current Medicinal Chemistry Unleashing the Potential of Microbial Natural Products in Drug Discovery: Focusing on <i>Streptomyces</i> as Antimicrobials Goldmine
Current Topics in Medicinal Chemistry Targeted Cancer Therapeutics: Biosynthetic and Energetic Pathways Characterized by Metabolomics and the Interplay with Key Cancer Regulatory Factors
Current Pharmaceutical Design IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets